Skip to main navigation
Skip to search
Skip to main content
Hong Kong Baptist University Home
Help & FAQ
Home
Scholars
Departments / Units
Research Output
Projects / Grants
Prizes / Awards
Activities
Press/Media
Student theses
Datasets
Search by expertise, name or affiliation
View Scopus Profile
Yuan MA, Dr
Research Assistant Professor
,
Chinese Medicine - Teaching and Research Division
https://orcid.org/0000-0002-7846-4863
Email
mayuan
hkbu.edu
hk
2014
2025
Research activity per year
Overview
Fingerprint
Network
Research Output
(36)
Prizes / Awards
(3)
Activities
(6)
Similar Scholars
(6)
Fingerprint
Dive into the research topics where Yuan MA is active. Topic labels come from the works of this scholar. Together they form a unique fingerprint.
Sort by:
Weight
Alphabetically
Keyphrases
Aptamer
100%
Small Interfering RNA (siRNA)
70%
Modification Strategies
30%
Lipids
29%
Sclerostin
28%
Binding Affinity
28%
Cationic Lipids
26%
High Affinity
23%
Triple-negative Breast Cancer
22%
Paclitaxel
22%
Affinity Enhancement
22%
HnRNPA1
20%
Modified Aptamers
19%
Nucleic Acids
17%
Bone Anabolic Effects
17%
Nucleic Acid Drug
17%
Duplex
16%
Hydrogen Bonds (H-bonds)
15%
Serum Stability
15%
Antisense Oligonucleotides
14%
Oligonucleotides
13%
Cancer Cells
13%
Gene Silencing
12%
Amphiphiles
11%
In Vivo Efficacy
11%
Nucleic Acid Aptamer
11%
Nanomedicine
10%
Aptamer Targeting
9%
Structural Optimization
9%
Aptamer-based
9%
Pharmacokinetics
9%
Cleavage Site
9%
Pancreatic Cancer Treatment
9%
Chemotherapy
9%
Tumor Microenvironment
9%
Targeted Therapy
9%
Nuclease
9%
Peptide Conjugation
8%
Annealing
8%
AS1411
8%
Ago2
8%
Targeted Delivery
8%
Artificial Intelligence
8%
Chemical Modification
8%
Osteogenesis Imperfecta
7%
Drug-resistant Lung Cancer
7%
Stability Improvement
7%
Bone Loss
7%
Rare Bone Disease
7%
Therapeutic Perspectives
7%
Pharmacology, Toxicology and Pharmaceutical Science
Aptamer
88%
Neoplasm
39%
Malignant Neoplasm
33%
Nucleic Acid
30%
Sclerostin
28%
Small Interfering RNA
26%
Paclitaxel
20%
Triple Negative Breast Cancer
18%
Chemotherapy
18%
Drug
17%
Heterogeneous Nuclear Ribonucleoprotein A1
15%
Pancreas Cancer
15%
Messenger RNA
15%
Antisense Oligonucleotide
14%
Oligonucleotide
14%
Melanoma
10%
Pharmacokinetic
9%
Tumor Microenvironment
8%
Tumor Growth
8%
Lung Cancer
7%
Drug Discovery
7%
Nucleolin
7%
Oblimersen
7%
microRNA 122
7%
Doxifluridine
7%
Metastasis
7%
Lipoplex
7%
Controlled Drug Release
7%
Liver Cell Carcinoma
7%
Nucleic Acid Base
7%
Hypoxia Inducible Factor
7%
Polyethylene Glycol
7%
Target Identification
7%
Bone Disease
7%
Plasmid DNA
7%
Hypoxia
7%
Prodrug
7%
Peptide Aptamer
7%
Osteogenesis Imperfecta
7%
Diseases
6%
Zeta Potential
6%
Gene Delivery
6%
Human Serum Albumin
5%
Ltvax
5%
Clinical Study
5%
Hydrogen Peroxide
5%
Carcinogenesis
5%
Biochemistry, Genetics and Molecular Biology
Aptamer
71%
Small Interfering RNA
39%
Lipid
25%
Binding Affinity
23%
Oligonucleotide
23%
Antisense
20%
Ribonucleoprotein
19%
Cationic Lipid
17%
Sclerostin
17%
Nuclease
16%
Nucleic Acid
12%
Tumor Progression
11%
Cancer Cell
9%
Bone Development
9%
Messenger RNA
9%
Gene Inactivation
9%
Nucleobase
8%
RNA-induced Silencing Complex
8%
Conformation
7%
KRAS
7%
Small RNAs
7%
Promoter Region
7%
Pharmacokinetic
7%
Transfection
7%
Hypoxia-Inducible Factors
7%
Drug Resistance
7%
Plasmid
7%
Programmed Cell Death
7%
